| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $2.3M | +34.9% |
| SG&A Expense | $6.5M | +130.1% |
| Operating Income | -$8.7M | -94.3% |
| Net Income | -$4.6M | +0.5% |
| EPS (Basic) | -$0.57 | +40.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.2M | +182.0% |
| Inventory | $186K | +52.3% |
| Current Assets | $4.4M | +174.9% |
| Total Assets | $11.8M | +100.6% |
| Current Liabilities | $2.0M | -27.5% |
| Total Liabilities | $2.2M | -20.5% |
| Stockholders' Equity | $9.6M | +207.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.4M | -104.4% |
| Capital Expenditures | $543K | -75.6% |
| Investing Cash Flow | -$3.1M | -33.0% |
| Financing Cash Flow | $12.2M | +136.2% |
| Free Cash Flow | -$7.0M | -29.9% |